In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product.

Lignende værker

• Prolonged survival of mice with human gastric cancer treated with an anti-c-ErbB-2 monoclonal antibody.
  af: Ohnishi, Y., et al.
  Udgivet: (1995)
• Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth.
  af: Harwerth, I. M., et al.
  Udgivet: (1993)
• A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
  af: Meng, Y, et al.
  Udgivet: (2016)
• Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo
  af: Lahlou, Hicham, et al.
  Udgivet: (2012)
• In vitro and in vivo anticancer efficacy of unconjugated humanised anti-CEA monoclonal antibodies
  af: Blumenthal, R D, et al.
  Udgivet: (2008)